Literature DB >> 8347734

Biotin labeling as an alternative nonradioactive approach to determination of red cell survival.

G Hoffmann-Fezer1, J Mysliwietz, W Mörtlbauer, H J Zeitler, E Eberle, U Hönle, S Thierfelder.   

Abstract

Biotin labeling of red cells was studied using different approaches to see if biotinylation is a useful label for determination of erythrocyte survival. Mouse red cells were labeled with biotin, either in vivo by injection or in vitro. In vivo labeled red cells were followed up in some mice without transfusing the labeled erythrocytes. Furthermore, in vivo labeled as well as in vitro labeled red cells were transfused into syngeneic mice. The biotin label allows an easy discrimination between labeled and unlabeled red cells during FACS analysis, and it is relatively stable for at least 50 days. All the three different approaches give similar results. Mean red cell life spans of in vivo or in vitro labeled red cells either transfused or followed up in vivo were between 44 and 52 days (T50 mean 23.9 days) when red cell destruction was assumed to be only a result of senescence. Mean red cell life spans were between 8 and 18 days (T50 mean 9.5 days) when a random destruction independent of red cell age was suggested. All the survival slopes are neither simple linear functions of time nor logarithmic functions, but they show an overlay of linear function by a logarithmic function where the components of both are unknown.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347734     DOI: 10.1007/bf01788131

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  17 in total

1.  The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in vivo.

Authors:  L M VAN PUTTEN
Journal:  Blood       Date:  1958-08       Impact factor: 22.113

2.  Effect of age on some properties of mice erythrocytes.

Authors:  M Magnani; L Rossi; V Stocchi; L Cucchiarini; G Piacentini; G Fornaini
Journal:  Mech Ageing Dev       Date:  1988-01       Impact factor: 5.432

3.  In vivo aging of red cell enzymes: study of biotinylated red blood cells in rabbits.

Authors:  A Zimran; L Forman; T Suzuki; G L Dale; E Beutler
Journal:  Am J Hematol       Date:  1990-04       Impact factor: 10.047

Review 4.  Red cell survival studies reinterpreted.

Authors:  S A Bentley
Journal:  Clin Haematol       Date:  1977-10

5.  Rare-event analysis methods for detection of fetal red blood cells in maternal blood.

Authors:  J E Cupp; J F Leary; E Cernichiari; J C Wood; R A Doherty
Journal:  Cytometry       Date:  1984-03

6.  Density fractionation of erythrocytes by Percoll/hypaque results in only a slight enrichment for aged cells.

Authors:  G L Dale; S L Norenberg
Journal:  Biochim Biophys Acta       Date:  1990-12-06

Review 7.  Biotin in clinical medicine--a review.

Authors:  K S Roth
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

8.  Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies.

Authors:  G Hoffmann-Fezer; H Maschke; H J Zeitler; P Gais; W Heger; J Ellwart; S Thierfelder
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

9.  Biotinylated erythrocytes: in vivo survival and in vitro recovery.

Authors:  T Suzuki; G L Dale
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

10.  The measurement of the total volume of red cells in man: a non-radioactive approach using biotin.

Authors:  I Cavill; D Trevett; J Fisher; T Hoy
Journal:  Br J Haematol       Date:  1988-12       Impact factor: 6.998

View more
  25 in total

1.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis.

Authors:  Dragan Marinkovic; Xin Zhang; Safak Yalcin; Julia P Luciano; Carlo Brugnara; Tara Huber; Saghi Ghaffari
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.

Authors:  Cécile Onclinx; Sophie Dogne; Laurence Jadin; Fabienne Andris; Christian Grandfils; François Jouret; François Mullier; Bruno Flamion
Journal:  Haematologica       Date:  2015-05-01       Impact factor: 9.941

3.  Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells.

Authors:  R S Franco; J Lohmann; E B Silberstein; G Mayfield-Pratt; M Palascak; T A Nemeth; C H Joiner; M Weiner; D L Rucknagel
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

Review 4.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

5.  Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3.

Authors:  Y Wang; A Gao; H Zhao; P Lu; H Cheng; F Dong; Y Gong; S Ma; Y Zheng; H Zhang; Y Zhang; J Xu; X Zhu; W Yuan; X Zhang; S Hao; T Cheng
Journal:  Leukemia       Date:  2016-04-25       Impact factor: 11.528

6.  Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.

Authors:  Aslihan Turhan; Linnea A Weiss; Narla Mohandas; Barry S Coller; Paul S Frenette
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

7.  Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.

Authors:  P V Browne; O Shalev; F A Kuypers; C Brugnara; A Solovey; N Mohandas; S L Schrier; R P Hebbel
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

8.  Determination of RBC Survival in C57BL/6 and C57BL/6-Tg(UBC-GFP) Mice.

Authors:  Urshulaa Dholakia; Sheila Bandyopadhyay; Eldad A Hod; Kevin A Prestia
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

9.  Essential role for Nix in autophagic maturation of erythroid cells.

Authors:  Hector Sandoval; Perumal Thiagarajan; Swapan K Dasgupta; Armin Schumacher; Josef T Prchal; Min Chen; Jin Wang
Journal:  Nature       Date:  2008-05-04       Impact factor: 49.962

10.  Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

Authors:  Robert M Cohen; Robert S Franco; Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Peter J Ciraolo; Mary B Palascak; Clinton H Joiner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.